Pennant Group Inc (NAS:PNTG)

Q2 2026 The Pennant Group, Inc. Earnings Call Transcript

Aug 6, 2026 / 04:00 PM GMT

Release Date Price: $39.06 (+0.63%)

Transcript 10-Q8-K

Key Points

Positve

Pennant Group Inc (PNTG) reported strong Q2 2026 results with revenue up 35.8% and adjusted EBITDA up 48.2% year-over-year, putting the company on pace to exceed the top end of its original guidance.
The company raised its full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted EPS, reflecting strong momentum and successful integration of recent acquisitions.
Same-store home health and hospice operations showed robust organic growth, with Medicare admissions up 13.6% and hospice ADC up 10.8% year-over-year, demonstrating strong market share gains.
The 2027 proposed home health rule includes a 2.4% base rate increase, a positive shift after four consecutive years of cuts, which the company is modeling as a 1.7% increase for its operations.
The company is expanding strategically through partnerships and acquisitions, including an equity investment in Hartford HealthCare at Home, which provides a platform for growth in the Northeast and strengthens its national presence.
Clinical quality remains a key strength, with an average CMS star rating of 4.1 versus the national average of 3.0 and a potentially preventable hospitalization rate of 10%, which is better than the national average of 10.8%.

Negative

The integration of the large Southeast acquisition is still in progress, with the largest transition waves continuing through October, which will naturally cause ongoing disruption and variability in results.
The hospice industry is under intense scrutiny due to fraud and abuse issues, leading to new administrative costs and stricter program integrity measures that could impact operations.
Revenue per episode in home health decreased by 1.9% year-over-year due to the mix of new Southeast operations, which have lower CMS wage indexes and lower revenue per episode.
The company anticipates lumpiness in senior living margins in Q3 and Q4 as it integrates newly acquired communities, many of which have low occupancy and require significant investment.
Elevated capital expenditures are expected, particularly for distressed senior living buildings acquired in late 2025, which will require spending to bring them up to company standards.
Debt levels increased during the quarter, primarily due to the investment in Hartford HealthCare at Home, and the company faces elevated interest expense as it manages this debt.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PNTG.OQ - The Pennant Group, Inc.
Q2 2026 The Pennant Group, Inc. Earnings Call
Aug 06, 2026 / 04:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the Pennant Group's second quarter 2026 earnings conference call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star one one on your telephone. You will then hear an automated message advising your hand is raised. Please note that today's conference is being recorded. I would now like to end the. Over to your first speaker today. Kirk Cheney, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.